glp 1 antibody GLP-1R (D-6) Human GLP-1 Antibody MAB12491: R&D
Description
The Revolutionary Role of GLP-1 Agonists and SGLT-2 Inhibitors in Managing Diabetes and Chronic Kidney Disease Shankar Chakkera, Elizabeth J
Obesity is a chronic disease associated with increased risk of obesity-related complications and mortality
April 29, 2024
While the overall frequency of liver enzyme elevations across the over 1,400 participant safety database of danuglipron is in-line with approved agents in the class, a single asymptomatic participant in one of the dose-optimization studies experienced potential drug-induced liver injury which resolved after discontinuation of danuglipron
Learn when and how to introduce GLP-1 during weight management consultations using evidence-based approach for sustainable results.
May help support metabolism and craving control throughout the day Daily Use Convenience: Simply apply the GLP-1 patch to clean, dry skin
